{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:38:34Z","timestamp":1789162714738,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jsat.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T12:37:41Z","timestamp":1431002261000},"page":"70-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence"],"prefix":"10.1016","volume":"57","author":[{"given":"Aimee L.","family":"McRae-Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Sonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lindsay","family":"DeVane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2015.05.002_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"Anderson","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.05.002_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00844747","article-title":"How useful is riboflavin as a tracer of medication compliance?","volume":"12","author":"Babiker","year":"1989","journal-title":"Journal of Behavioral Medicine"},{"key":"10.1016\/j.jsat.2015.05.002_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1530-0277.2007.00343.x","article-title":"What role does measuring medication compliance play in evaluating the efficacy of naltrexone?","volume":"31","author":"Baros","year":"2007","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2015.05.002_bb0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0895-4356(93)90018-V","article-title":"Bias, prevalence and kappa","volume":"46","author":"Byrt","year":"1993","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.jsat.2015.05.002_bb0025","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1177\/0091270006292250","article-title":"Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range","volume":"46","author":"Dockens","year":"2006","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jsat.2015.05.002_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/bdd.566","article-title":"Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans","volume":"28","author":"Dockens","year":"2007","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1016\/j.jsat.2015.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.jsat.2015.05.002_bb0040","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/01.ALC.0000080670.59386.6E","article-title":"Measurement and prediction of medication compliance in problem drinkers","volume":"27","author":"Feinn","year":"2003","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2015.05.002_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugalcdep.2012.08.007","article-title":"Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement","volume":"128","author":"Herron","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.05.002_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.adt.0000132509.65041.bf","article-title":"Comparing measures of medication taking in a pharmacotherapy trial for cocaine dependence","volume":"3","author":"Mooney","year":"2004","journal-title":"Addictive Disorders and Their Treatment"},{"key":"10.1016\/j.jsat.2015.05.002_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","article-title":"Akaike's information criterion in generalized estimating equations","volume":"57","author":"Pan","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.jsat.2015.05.002_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/02791072.1999.10471727","article-title":"Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders","volume":"31","author":"Sowers","year":"1999","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2015.05.002_bb0065","series-title":"Patient compliance in medical practice and clinical trials","first-page":"37","article-title":"Methods of assessing and improving patient compliance in clinical trials","author":"Spilker","year":"1991"},{"key":"10.1016\/j.jsat.2015.05.002_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10461-012-0172-7","article-title":"A proposal for quality standards for measuring adherence in research","volume":"17","author":"Williams","year":"2013","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2015.05.002_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:43:55Z","timestamp":1760039035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547215001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":15,"alternative-id":["S0740547215001075"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2015.05.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2015.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}